The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review S. Hoyer Pages: 991 - 1002
The cholinergic pathology in Alzheimer's disease – discrepancies between clinical experience and pathophysiological findings L. Frölich Pages: 1003 - 1013
Increase of transcriptional levels of egr-1 and nur77 genes due to both nicotine treatment and withdrawal in pheochromocytoma cells N. IchinoK. YamadaH. Ishiguro Pages: 1015 - 1022
No association of the −48CT polymorphism of the presenilin 1 gene with Alzheimer disease in a late-onset sporadic population L. Araria-GoumidiJ. B. HuguetM. C. Chartier-Harlin Pages: 1023 - 1027
The insulin gene VNTR polymorphism in Alzheimer's disease: results of a pilot study M. MajoresH. KölschR. Heun Pages: 1029 - 1034
Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease J. A. MolinaF. J. Jiménez-JiménezY. Sayed Pages: 1035 - 1044
Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit E. GiacobiniR. SpiegelN. R. Cutler Pages: 1053 - 1065
Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats C. ScaliF. CasamentiG. Pepeu Pages: 1067 - 1080
Potential neurotoxic inflammatory responses to Aβ vaccination in humans G. MünchS. R. Robinson Pages: 1081 - 1087
Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent M. PanissetS. Gauthierand The Cerebrolysin Study Group Pages: 1089 - 1104
β-CIT SPECT demonstrates reduced availability of serotonin transporters in patients with Fatal Familial Insomnia S. KlöppelW. PirkerG. Almer Short Communication Pages: 1105 - 1110
